Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-04 01:28 | 2015-12-01 | XTNT | Xtant Medical Holdings, Inc. | Swanson Kent L | Director | BUY | $2.83 | 3,300 | $9,343 | 83,128 |
| 2015-12-04 04:31 | 2015-12-02 | IRMD | IRADIMED CORP | JOHNSON BRENT | Officer | OPT+S | $31.52 | 26,880 | $847,287 | 0 |
| 2015-12-03 00:29 | 2015-11-30 | MMSI | MERIT MEDICAL SYSTEMS INC | Birkett Bernard | Officer | OPT+S | $19.31 | 3,750 | $72,413 | 1,075 |
| 2015-12-03 00:11 | 2015-12-01 | BSX | BOSTON SCIENTIFIC CORP | Pratt Timothy A. | Officer | OPT+S | $18.43 | 24,000 | $442,414 | 282,295 |
| 2015-12-03 00:13 | 2015-12-01 | TNDM | TANDEM DIABETES CARE INC | Sheridan John F | Officer | OPT+S | $10.14 | 2,000 | $20,280 | 4,084 |
| 2015-12-02 21:59 | 2015-12-01 | IRMD | IRADIMED CORP | Novovich Serge | Director | OPT+S | $31.12 | 1,000 | $31,123 | 100,983 |
| 2015-12-03 00:29 | 2015-11-30 | MMSI | MERIT MEDICAL SYSTEMS INC | PERRY RASHELLE | Officer | OPT+S | $19.36 | 12,500 | $242,026 | 9,435 |
| 2015-12-03 04:01 | 2015-11-30 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $86.50 | 5,000 | $432,500 | 459,018 |
| 2015-12-02 17:30 | 2015-12-01 | BDX | BECTON DICKINSON & CO | Polen Thomas E Jr | Officer | SELL | $152.21 | 2,683 | $408,379 | 5,789 |
| 2015-12-02 02:31 | 2015-12-01 | HART | Harvard Apparatus Regenerative Technology, Inc. | LaFrancesca Saverio | Officer | BUY | $3.01 | 10,000 | $30,052 | 43,998 |
| 2015-12-02 01:48 | 2015-11-27 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $15.73 | 37,184 | $584,889 | 70,420 |
| 2015-12-02 02:31 | 2015-12-01 | HART | Harvard Apparatus Regenerative Technology, Inc. | KENNEDY JOHN F | Director | BUY | $2.95 | 9,000 | $26,525 | 35,724 |
| 2015-12-02 00:35 | 2015-11-27 | CRY | Artivion Inc. | LEE DAVID ASHLEY | Officer | OPT+S | $11.03 | 11,800 | $130,148 | 239,969 |
| 2015-12-01 18:17 | 2015-11-30 | BDX | BECTON DICKINSON & CO | Gallagher John E | Officer | SELL | $150.70 | 1,600 | $241,120 | 3,393 |
| 2015-12-01 02:01 | 2015-11-25 | IRMD | IRADIMED CORP | HAWKINS JAMES B | Director | SELL | $31.27 | 3,460 | $108,186 | 80,000 |
| 2015-12-01 01:59 | 2015-11-25 | IRMD | IRADIMED CORP | HAWKINS JAMES B | Director | OPT+S | $30.98 | 5,290 | $163,872 | 83,460 |
| 2015-11-30 23:08 | 2015-11-27 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $97.58 | 12,000 | $1,170,912 | 8,730,233 |
| 2015-12-01 03:56 | 2015-11-03 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $58.09 | 5,585 | $324,433 | 74,287 |
| 2015-12-01 04:30 | 2015-11-25 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $87.53 | 15,000 | $1,312,898 | 459,018 |
| 2015-12-01 04:29 | 2015-11-25 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $87.49 | 7,500 | $656,192 | 107,680 |
| 2015-12-01 00:32 | 2015-11-25 | ICUI | ICU MEDICAL INC/DE | SWINNEY ROBERT S | Director | SELL | $112.00 | 3,000 | $336,000 | 17,758 |
| 2015-11-30 21:17 | 2015-11-25 | WST | WEST PHARMACEUTICAL SERVICES INC | Paproski John E | Officer | OPT+S | $63.41 | 17,560 | $1,113,473 | 70,288 |
| 2015-11-26 00:44 | 2015-11-24 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $96.04 | 12,000 | $1,152,430 | 8,742,233 |
| 2015-11-26 00:02 | 2015-11-23 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | SELL | $15.96 | 10,000 | $159,552 | 170,839 |
| 2015-11-26 00:01 | 2015-11-23 | LMAT | LEMAITRE VASCULAR INC | Pellegrino Joseph P JR | Officer | OPT+S | $15.57 | 45,840 | $713,509 | 110,389 |
| 2015-11-26 00:01 | 2015-11-23 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $15.31 | 11,971 | $183,278 | 70,420 |
| 2015-11-26 01:19 | 2015-11-24 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $86.54 | 15,497 | $1,341,103 | 459,018 |
| 2015-11-24 19:12 | 2015-11-20 | MMM | 3M CO | Bauman James L | Officer | OPT+S | $159.50 | 5,392 | $860,024 | 8,686 |
| 2015-11-25 04:29 | 2015-11-20 | RMD | RESMED INC | Reiser Anne | Officer | OPT+S | $59.02 | 3,400 | $200,671 | 76,300 |
| 2015-11-25 03:50 | 2015-11-20 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director | SELL | $15.61 | 41,135 | $642,080 | 226,881 |
| 2015-11-25 03:26 | 2015-11-20 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $15.63 | 65,052 | $1,017,003 | 3,633,333 |
| 2015-11-25 03:37 | 2015-11-23 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $85.84 | 14,000 | $1,201,781 | 216,214 |
| 2015-11-25 03:37 | 2015-11-23 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | SELL | $85.85 | 1,666 | $143,024 | 20,071 |
| 2015-11-25 03:36 | 2015-11-23 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $86.43 | 10,000 | $864,334 | 113,157 |
| 2015-11-23 22:13 | 2015-11-20 | XTNT | Xtant Medical Holdings, Inc. | Kirschman David Louis | Director, Officer, 10% owner | BUY | $2.99 | 2,000 | $5,983 | 1,701,063 |
| 2015-11-23 20:18 | 2015-11-19 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $96.74 | 18,000 | $1,741,289 | 8,754,233 |
| 2015-11-23 21:20 | 2015-11-20 | UFPT | UFP TECHNOLOGIES INC | GESTAL KENNETH L | Director | OPT+S | $23.59 | 4,541 | $107,106 | 3,329 |
| 2015-11-24 04:04 | 2015-11-20 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $59.03 | 12,000 | $708,380 | 323,900 |
| 2015-11-24 05:39 | 2015-11-19 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $14.40 | 19,900 | $286,592 | 70,420 |
| 2015-11-24 03:04 | 2015-11-19 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $86.48 | 22,003 | $1,902,727 | 459,018 |
| 2015-11-21 00:06 | 2015-11-16 | INFU | InfuSystem Holdings, Inc | Steen Eric K | Director, Officer | BUY | $2.93 | 5,280 | $15,470 | 162,497 |
| 2015-11-21 02:22 | 2015-11-19 | XTNT | Xtant Medical Holdings, Inc. | Swanson Kent L | Director | BUY | $3.00 | 5,000 | $14,998 | 79,828 |
| 2015-11-21 02:36 | 2015-11-18 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $96.62 | 6,000 | $579,739 | 8,772,233 |
| 2015-11-20 22:11 | 2015-11-18 | UFPT | UFP TECHNOLOGIES INC | GESTAL KENNETH L | Director | OPT+S | $23.72 | 15,447 | $366,429 | 3,329 |
| 2015-11-21 05:47 | 2015-11-18 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $14.37 | 100 | $1,437 | 70,420 |
| 2015-11-21 05:16 | 2015-11-18 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | SELL | $14.73 | 10,000 | $147,256 | 180,839 |
| 2015-11-20 01:08 | 2015-11-19 | HART | Harvard Apparatus Regenerative Technology, Inc. | McGorry James Joseph | Director, Officer | BUY | $1.79 | 10,000 | $17,900 | 71,300 |
| 2015-11-19 19:06 | 2015-11-18 | XTNT | Xtant Medical Holdings, Inc. | Kirschman David Louis | Director, Officer, 10% owner | BUY | $2.90 | 2,000 | $5,805 | 1,699,063 |
| 2015-11-20 01:11 | 2015-11-19 | HART | Harvard Apparatus Regenerative Technology, Inc. | McNaughton Thomas | Officer | BUY | $1.70 | 10,000 | $17,000 | 201,128 |
| 2015-11-20 02:09 | 2015-11-17 | INFU | InfuSystem Holdings, Inc | Steen Eric K | Director, Officer | BUY | $2.88 | 2,461 | $7,087 | 157,217 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.